Skip to main content
OpenTrials

Clinical trial condition

Attention Deficit and Disruptive Behavior Disorders

Explore clinical trials studying Attention Deficit and Disruptive Behavior Disorders. Study availability and eligibility vary by location and protocol.

1,451 public trials 168 recruiting studies
Refine in advanced search Browse all conditions

Attention Deficit and Disruptive Behavior Disorders trial results

Completed

Smoking Cessation for Adults With Attention Deficit Hyperactivity Disorder (ADHD)

NCT00253747

Conditions
ADHD, Attention Deficit Disorder with Hyperactivity, Attention Deficit and Disruptive Behavior Disorders, +4 more
Locations
  • Massachusetts General Hospital Cambridge, Massachusetts, United States
  • Mayo Clinic Nicotine Research Program Rochester, Minnesota, United States
  • VA New York Harbor Healthcare System New York, United States
  • New York State Psychiatric Institute - Smoking Cessation Program New York, United States
View Trial Details
Completed

Atomoxetine to Treat Asian Adult Patients With Attention-Deficit/Hyperactivity Disorder

NCT00962104

Conditions
Attention Deficit Disorder with Hyperactivity, Attention Deficit Hyperactivity Disorder, Attention Deficit and Disruptive Behavior Disorders, +2 more
Locations
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Aichi, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Chiba, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Fukushima, Japan
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Hokkaido, Japan
View all 24 locations
View Trial Details

Related conditions